200 related articles for article (PubMed ID: 24358214)
21. Entropy and gravity concepts as new methodological indexes to investigate technological convergence: patent network-based approach.
Cho Y; Kim M
PLoS One; 2014; 9(6):e98009. PubMed ID: 24914959
[TBL] [Abstract][Full Text] [Related]
22. China's non-ferrous metal recycling technology convergence and driving factors: A quadratic assignment procedure analysis based on patent collaboration-based network structural hole.
Luo K; Zor S
PLoS One; 2022; 17(8):e0271694. PubMed ID: 35930587
[TBL] [Abstract][Full Text] [Related]
23. Pharma industry in India.
Sundaram VM
Drug News Perspect; 2008; 21(1):59-63. PubMed ID: 18301810
[TBL] [Abstract][Full Text] [Related]
24. Financial Times Global Pharmaceutical & Biotechnology Conference 2009.
Scattereggia J
IDrugs; 2010 Jan; 13(1):26-9. PubMed ID: 20024844
[TBL] [Abstract][Full Text] [Related]
25. Dengue Vaccines: A Perspective from the Point of View of Intellectual Property.
da Veiga CP; da Veiga CR; Del Corso JM; da Silva WV
Int J Environ Res Public Health; 2015 Aug; 12(8):9454-74. PubMed ID: 26274968
[TBL] [Abstract][Full Text] [Related]
26. Using patent data to assess the value of pharmaceutical innovation.
Kesselheim AS; Avorn J
J Law Med Ethics; 2009; 37(2):176-83. PubMed ID: 19493065
[TBL] [Abstract][Full Text] [Related]
27. Flows of knowledge from universities and federal laboratories: modeling the flow of patent citations over time and across institutional and geographic boundaries.
Jaffe AB; Trajtenberg M
Proc Natl Acad Sci U S A; 1996 Nov; 93(23):12671-7. PubMed ID: 8917478
[TBL] [Abstract][Full Text] [Related]
28. Evolution of technology convergence networks in Korea: Characteristics of temporal changes in R&D according to institution type.
Choi JY; Jeong S; Jung JK
PLoS One; 2018; 13(2):e0192195. PubMed ID: 29420574
[TBL] [Abstract][Full Text] [Related]
29. The biotechnology innovation machine: a source of intelligent biopharmaceuticals for the pharma industry--mapping biotechnology's success.
Evens RP; Kaitin KI
Clin Pharmacol Ther; 2014 May; 95(5):528-32. PubMed ID: 24448474
[TBL] [Abstract][Full Text] [Related]
30. Herbal drug patenting in India: IP potential.
Sahoo N; Manchikanti P; Dey SH
J Ethnopharmacol; 2011 Sep; 137(1):289-97. PubMed ID: 21640810
[TBL] [Abstract][Full Text] [Related]
31. Challenges in discovering bioactives for the food industry.
Schwager J; Mohajeri MH; Fowler A; Weber P
Curr Opin Biotechnol; 2008 Apr; 19(2):66-72. PubMed ID: 18406130
[TBL] [Abstract][Full Text] [Related]
32. Knowledge mobilization between the food industry and public health nutrition scientists: findings from a case study.
Le Bouthillier M; Veilleux S; Loignon J; Turcotte M; Trudel L; Provencher V
BMC Nutr; 2024 Jun; 10(1):81. PubMed ID: 38845063
[TBL] [Abstract][Full Text] [Related]
33. An Overview on Indian Patents on Biotechnology.
Mallick A; Chandra Santra S; Samal AC
Recent Pat Biotechnol; 2015; 9(3):198-213. PubMed ID: 27012291
[TBL] [Abstract][Full Text] [Related]
34. Processing of food wastes.
Kosseva MR
Adv Food Nutr Res; 2009; 58():57-136. PubMed ID: 19878858
[TBL] [Abstract][Full Text] [Related]
35. The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance.
Fernald KD; Pennings HP; van den Bosch JF; Commandeur HR; Claassen E
PLoS One; 2017; 12(2):e0172488. PubMed ID: 28231332
[TBL] [Abstract][Full Text] [Related]
36. First-to-patent does not predict first- or best-in-class: analysis of approved small molecule vs. biologic drugs.
Roland GE; Xu JJ; Wagner JA
Clin Pharmacol Ther; 2015 Jan; 97(1):19-21. PubMed ID: 25670379
[TBL] [Abstract][Full Text] [Related]
37. [Food as medicine: the thin dividing line between the pharmaceutical industry and the food industry].
González Díaz C; Meléndez Illanes L; Alvarez-Dardet C
Rev Esp Salud Publica; 2012; 86(4):313-7. PubMed ID: 23076079
[No Abstract] [Full Text] [Related]
38. From maturity to value-added innovation: lessons from the pharmaceutical and agro-biotechnology industries.
Mittra J; Tait J; Wield D
Trends Biotechnol; 2011 Mar; 29(3):105-9. PubMed ID: 21163543
[TBL] [Abstract][Full Text] [Related]
39. Understanding the Dynamic Convergence Phenomenon from the Perspective of Diversity and Persistence: A Cross-Sector Comparative Analysis between the United States and South Korea.
Shim W; Kwon OJ; Moon YH; Kim KH
PLoS One; 2016; 11(7):e0159249. PubMed ID: 27416495
[TBL] [Abstract][Full Text] [Related]
40. The Pharma Summit 2010: competing in the future healthcare system.
Kibble A
IDrugs; 2010 Apr; 13(4):228-31. PubMed ID: 20373249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
